Trial · NCT05576051
Results by group126
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 126
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinical Disease Activity Index (CDAI) Score at 6 Months for Tofacitinib Monotherapy vs Tofacitinib With Methotrexate (MTX) | Tofacitinib Initiators Combination | All | 18.1 | Standard Deviation 15.1 | Units on a scale |
| Clinical Disease Activity Index (CDAI) Score at 6 Months for Tofacitinib Monotherapy vs Tofacitinib With Methotrexate (MTX) | Tofacitinib Initiators Monotherapy | All | 17 | Standard Deviation 13.4 | Units on a scale |
| Clinical Disease Activity Index (CDAI) Score at 6 Months for Tofacitinib Monotherapy vs Tofacitinib With Methotrexate (MTX) | Tofacitinib Initiators Combination | Non-switchers | 16.6 | Standard Deviation 14.3 | Units on a scale |
| Clinical Disease Activity Index (CDAI) Score at 6 Months for Tofacitinib Monotherapy vs Tofacitinib With Methotrexate (MTX) | Tofacitinib Initiators Monotherapy | Non-switchers | 14.6 | Standard Deviation 11.6 | Units on a scale |
| CDAI Score at 6 Months for Tumor Necrosis Factor Inhibitor (TNFi) Monotherapy vs TNFi Combination With MTX | All TNFi Initiators Combination | All | 13.9 | Standard Deviation 12.5 | Units on a scale |
| CDAI Score at 6 Months for Tumor Necrosis Factor Inhibitor (TNFi) Monotherapy vs TNFi Combination With MTX | All TNFI Initiators Monotherapy | All | 16.5 | Standard Deviation 13.8 | Units on a scale |
| CDAI Score at 6 Months for Tumor Necrosis Factor Inhibitor (TNFi) Monotherapy vs TNFi Combination With MTX | All TNFi Initiators Combination | Non-switchers | 13 | Standard Deviation 11.8 | Units on a scale |
| CDAI Score at 6 Months for Tumor Necrosis Factor Inhibitor (TNFi) Monotherapy vs TNFi Combination With MTX | All TNFI Initiators Monotherapy | Non-switchers | 14.9 | Standard Deviation 13 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Monotherapy vs TNFi Combination With MTX | All TNFi Initiators Combination | All | 13.9 | Standard Deviation 12.5 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Monotherapy vs TNFi Combination With MTX | Tofacitinib Initiators Monotherapy | All | 17 | Standard Deviation 13.4 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Monotherapy vs TNFi Combination With MTX | All TNFi Initiators Combination | Non-switchers | 13 | Standard Deviation 11.8 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Monotherapy vs TNFi Combination With MTX | Tofacitinib Initiators Monotherapy | Non-switchers | 14.6 | Standard Deviation 11.6 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Monotherapy | All TNFI Initiators Monotherapy | All | 16.5 | Standard Deviation 13.8 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Monotherapy | Tofacitinib Initiators Combination | All | 18.1 | Standard Deviation 15.1 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Monotherapy | All TNFI Initiators Monotherapy | Non-switchers | 14.9 | Standard Deviation 13 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Monotherapy | Tofacitinib Initiators Combination | Non-switchers | 16.6 | Standard Deviation 14.3 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Combination With MTX | All TNFi Initiators Combination | All | 13.9 | Standard Deviation 12.5 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Combination With MTX | Tofacitinib Initiators Combination | All | 18.1 | Standard Deviation 15.1 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Combination With MTX | All TNFi Initiators Combination | Non-switchers | 13 | Standard Deviation 11.8 | Units on a scale |
| CDAI Score at 6 Months for Tofacitinib Combination With MTX vs TNFi Combination With MTX | Tofacitinib Initiators Combination | Non-switchers | 16.6 | Standard Deviation 14.3 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05576051/results